Reports
Reports
The global periodic fever syndrome market is expected to witness a steady growth in the forecast period of 2023-2028.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America is one of the leading regions in the global periodic fever syndrome industry. The region accounts for a significant share of the total market value owing to the growing penetration of the major players in the region and the greater focus on patient care and monitoring. The growing investments in the research and development activities, coupled with the availability of advanced healthcare infrastructure in the region, are aiding the industry growth in North America. However, there still remains the difficulty in the diagnosis of periodic fever syndrome due to unrelated symptoms, which is a key challenge faced by the market players.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Periodic fever syndromes are a group of rare autoinflammatory diseases in which a patient experiences recurrent episodes of fever over time, usually accompanied by similar symptoms. The disease causes periodic (episodic) fever, often accompanied by rashes and joint pain, that do not have an infectious (virus, bacteria) cause, and each episode of fever usually lasts roughly the same length of time. These disorders are genetic conditions and are very rare. Among children, periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is the most common type of periodic fever syndrome. These disorders are milder and less obvious in adults than in children.
On the basis of treatment, the market is divided into:
By indication, the industry can be segmented into:
The various routes of administration are:
The major distribution channels in the industry include:
Based on end use sector, the industry can be categorised into:
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
There is limited knowledge and limited treatment options available for periodic fever syndrome. The growing government initiatives to raise public awareness regarding such rare disorders are aiding the industry growth. Currently, the treatment of periodic fever syndrome is carried out using oral anti-inflammatory drugs, such as corticosteroids, and non-steroidal anti-inflammatory drugs (NSAIDs), among others, which helps to control the symptoms associated with the disease but does not assist in its elimination. However, the rapid technological advancements and the growing research activities are leading to the development of improved diagnostic facilities and new drugs and therapies. The new drug approvals for the treatment of this rare disorder is expected to have a positive effect on the expansion of the periodic fever syndrome industry. In developed nations, the growing government investments in the development of healthcare infrastructure will further boost the market expansion over the forecast period.
The report gives a detailed analysis of the following key players in the global periodic fever syndrome market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2018-2022 |
Forecast Period | 2023-2028 |
Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Treatment, Indication, Route of Administration, Distribution Channel, End Use, Region |
Breakup by Treatment | Oral Anti-Inflammatory Drugs, Non-Steroidal Anti-Inflammatory Drugs, Anti-TNF Therapy, Statins, Others |
Breakup by Indication | Hyperimmunoglobulinemia D Syndrome, Familial Mediterranean Fever, TNF Receptor-Associated Periodic Syndrome, Cryopyrin-Associated Periodic Syndrome, Others |
Breakup by Route of Administration | Oral, Injections, Others |
Breakup by Distribution Channel | Hospital Pharmacy, Retail Pharmacy, Online, Others |
Breakup by End Use | Hospitals, Speciality Centres, Others |
Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
Companies Covered | Swedish Orphan Biovitrum AB, Novartis AG, Texas Allergy Group, PLLC, Others |
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and End Uses
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Periodic Fever Syndrome Market Analysis
8.1 Key Industry Highlights
8.2 Global Periodic Fever Syndrome Historical Market (2018-2022)
8.3 Global Periodic Fever Syndrome Market Forecast (2023-2028)
8.4 Global Periodic Fever Syndrome Market by Treatment
8.4.1 Oral Anti-Inflammatory Drugs
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Non-Steroidal Anti-Inflammatory Drugs
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.3 Anti-TNF Therapy
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2022)
8.4.3.3 Forecast Trend (2023-2028)
8.4.4 Statins
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2018-2022)
8.4.4.3 Forecast Trend (2023-2028)
8.4.5 Others
8.5 Global Periodic Fever Syndrome Market by Indication
8.5.1 Hyperimmunoglobulinemia D Syndrome
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Familial Mediterranean Fever
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 TNF Receptor-Associated Periodic Syndrome
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.4 Cryopyrin-Associated Periodic Syndrome
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2018-2022)
8.5.4.3 Forecast Trend (2023-2028)
8.5.5 Others
8.6 Global Periodic Fever Syndrome Market by Route of Administration
8.6.1 Oral
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Injections
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Others
8.7 Global Periodic Fever Syndrome Market by Distribution Channel
8.7.1 Hospital Pharmacy
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2018-2022)
8.7.1.3 Forecast Trend (2023-2028)
8.7.2 Retail Pharmacy
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2018-2022)
8.7.2.3 Forecast Trend (2023-2028)
8.7.3 Online
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2018-2022)
8.7.3.3 Forecast Trend (2023-2028)
8.7.4 Others
8.8 Global Periodic Fever Syndrome Market by End Use
8.8.1 Hospitals
8.8.1.1 Market Share
8.8.1.2 Historical Trend (2018-2022)
8.8.1.3 Forecast Trend (2023-2028)
8.8.2 Speciality Centres
8.8.2.1 Market Share
8.8.2.2 Historical Trend (2018-2022)
8.8.2.3 Forecast Trend (2023-2028)
8.8.3 Others
8.9 Global Periodic Fever Syndrome Market by Region
8.9.1 North America
8.9.1.1 Market Share
8.9.1.2 Historical Trend (2017-2021)
8.9.1.3 Forecast Trend (2022-2027)
8.9.2 Europe
8.9.2.1 Market Share
8.9.2.2 Historical Trend (2017-2021)
8.9.2.3 Forecast Trend (2022-2027)
8.9.3 Asia Pacific
8.9.3.1 Market Share
8.9.3.2 Historical Trend (2017-2021)
8.9.3.3 Forecast Trend (2022-2027)
8.9.4 Latin America
8.9.4.1 Market Share
8.9.4.2 Historical Trend (2017-2021)
8.9.4.3 Forecast Trend (2022-2027)
8.9.5 Middle East and Africa
8.9.5.1 Market Share
8.9.5.2 Historical Trend (2017-2021)
8.9.5.3 Forecast Trend (2022-2027)
9 North America Periodic Fever Syndrome Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2017-2021)
9.1.3 Forecast Trend (2022-2027)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2017-2021)
9.2.3 Forecast Trend (2022-2027)
10 Europe Periodic Fever Syndrome Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2017-2021)
10.1.3 Forecast Trend (2022-2027)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2017-2021)
10.2.3 Forecast Trend (2022-2027)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2017-2021)
10.3.3 Forecast Trend (2022-2027)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2017-2021)
10.4.3 Forecast Trend (2022-2027)
10.5 Others
11 Asia Pacific Periodic Fever Syndrome Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2017-2021)
11.1.3 Forecast Trend (2022-2027)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2017-2021)
11.2.3 Forecast Trend (2022-2027)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2017-2021)
11.3.3 Forecast Trend (2022-2027)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2017-2021)
11.4.3 Forecast Trend (2022-2027)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2017-2021)
11.5.3 Forecast Trend (2022-2027)
11.6 Others
12 Latin America Periodic Fever Syndrome Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2017-2021)
12.1.3 Forecast Trend (2022-2027)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2017-2021)
12.2.3 Forecast Trend (2022-2027)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2017-2021)
12.3.3 Forecast Trend (2022-2027)
12.4 Others
13 Middle East and Africa Periodic Fever Syndrome Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2017-2021)
13.1.3 Forecast Trend (2022-2027)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2017-2021)
13.2.3 Forecast Trend (2022-2027)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2017-2021)
13.3.3 Forecast Trend (2022-2027)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2017-2021)
13.4.3 Forecast Trend (2022-2027)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Swedish Orphan Biovitrum AB
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Novartis AG
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 Texas Allergy Group, PLLC
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Periodic Fever Syndrome Market: Key Industry Highlights, 2018 and 2028
2. Global Periodic Fever Syndrome Historical Market: Breakup by Treatment (USD Billion), 2018-2022
3. Global Periodic Fever Syndrome Market Forecast: Breakup by Treatment (USD Billion), 2023-2028
4. Global Periodic Fever Syndrome Historical Market: Breakup by Indication (USD Billion), 2018-2022
5. Global Periodic Fever Syndrome Market Forecast: Breakup by Indication (USD Billion), 2023-2028
6. Global Periodic Fever Syndrome Historical Market: Breakup by Route of Administration (USD Billion), 2018-2022
7. Global Periodic Fever Syndrome Market Forecast: Breakup by Route of Administration (USD Billion), 2023-2028
8. Global Periodic Fever Syndrome Historical Market: Breakup by Distribution Channel (USD Billion), 2018-2022
9. Global Periodic Fever Syndrome Market Forecast: Breakup by Distribution Channel (USD Billion), 2023-2028
10. Global Periodic Fever Syndrome Historical Market: Breakup by End Use (USD Billion), 2018-2022
11. Global Periodic Fever Syndrome Market Forecast: Breakup by End Use (USD Billion), 2023-2028
12. Global Periodic Fever Syndrome Historical Market: Breakup by Region (USD Billion), 2018-2022
13. Global Periodic Fever Syndrome Market Forecast: Breakup by Region (USD Billion), 2023-2028
14. North America Periodic Fever Syndrome Historical Market: Breakup by Country (USD Billion), 2018-2022
15. North America Periodic Fever Syndrome Market Forecast: Breakup by Country (USD Billion), 2023-2028
16. Europe Periodic Fever Syndrome Historical Market: Breakup by Country (USD Billion), 2018-2022
17. Europe Periodic Fever Syndrome Market Forecast: Breakup by Country (USD Billion), 2023-2028
18. Asia Pacific Periodic Fever Syndrome Historical Market: Breakup by Country (USD Billion), 2018-2022
19. Asia Pacific Periodic Fever Syndrome Market Forecast: Breakup by Country (USD Billion), 2023-2028
20. Latin America Periodic Fever Syndrome Historical Market: Breakup by Country (USD Billion), 2018-2022
21. Latin America Periodic Fever Syndrome Market Forecast: Breakup by Country (USD Billion), 2023-2028
22. Middle East and Africa Periodic Fever Syndrome Historical Market: Breakup by Country (USD Billion), 2018-2022
23. Middle East and Africa Periodic Fever Syndrome Market Forecast: Breakup by Country (USD Billion), 2023-2028
24. Global Periodic Fever Syndrome Market Structure
The global periodic fever syndrome market is estimated to witness a steady growth in the forecast period of 2023-2028.
The major drivers of the industry, such as rising disposable incomes, increasing population, rising focus on patient care and monitoring, increasing government initiatives to raise public awareness regarding such rare disorders, growing technological advancements, rising research activities, and new drug approvals for the treatment, are expected to aid the market growth.
The key trends guiding the growth of the market include the rising investments in the research and development activities and the increasing availability of advanced healthcare infrastructure.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading treatments of periodic fever syndrome in the market are oral anti-inflammatory drugs, non-steroidal anti-inflammatory drugs, anti-TNF therapy, and statins, among others.
The major indications of periodic fever syndrome in the industry are hyperimmunoglobulinemia D syndrome, familial mediterranean fever, TNF receptor-associated periodic syndrome, and cryopyrin-associated periodic syndrome, among others.
The significant routes of administration in the market are oral and injections, among others.
The major distribution channels in the industry are hospital pharmacy, retail pharmacy, and online, among others.
The leading end-use sectors in the market are hospitals and speciality centres, among others.
The major players in the industry are Swedish Orphan Biovitrum AB, Novartis AG, and Texas Allergy Group, PLLC, among others.
The global periodic fever syndrome market is being driven by the rising advancements in the healthcare sector. Aided by the rising R&D activities, the market is expected to witness a steady growth in the forecast period of 2023-2028.
EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on treatment, the market is segmented into oral anti-inflammatory drugs, non-steroidal anti-inflammatory drugs, anti-TNF therapy, and statins, among others. On the basis of indication, the market is divided into hyperimmunoglobulinemia D syndrome, familial mediterranean fever, TNF receptor-associated periodic syndrome, and cryopyrin-associated periodic syndrome, among others. By route of administration, the industry is segmented into oral and injections, among others. The leading distribution channels in the market are hospital pharmacy, retail pharmacy, and online, among others. Based on end use, the industry is divided into hospitals and speciality centres, among others. The major regional markets for periodic fever syndrome are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Swedish Orphan Biovitrum AB, Novartis AG, and Texas Allergy Group, PLLC, among others.
EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.